首页> 外国专利> Acrylamide derivatives useful as inhibitors of mitochondrial permeability transition

Acrylamide derivatives useful as inhibitors of mitochondrial permeability transition

机译:丙烯酰胺衍生物可用作线粒体通透性转变的抑制剂

摘要

A compound of general formula (I) ** Formula ** in which: W is aryl or heteroaryl; a is 0, 1, 2 or 3; R and R 'are the same or different and, independently of each other, are selected from: hydrogen; halogen; (C1-C3) alkoxy; haloalkoxy (C1-C2); haloalkyl (C1-C2); NR1R2; CN; SO2NH2; or optionally substituted (C1-C6) alkyl, aryl or heteroaryl; R "is independently selected from: halogen; (C1-C3) alkyl; (C1-C3) alkoxy; (C1-C3) alkoxyalkyl; C1-C2 haloalkoxy; (C1-C2) haloalkyl; NR3R4; or (CH2) nX- (CH2) mQ, in which: n, m independently, are 0, 1 or 2; X is a direct bond; O; S; NH; N-alkyl (C1-C3); Q is an optionally substituted aryl, heteroaryl , heterocycloalkyl or cycloalkyl; R1, R2, R3 and R4 are the same or different and, independently of each other, are a hydrogen atom; a (C1-C3) alkyl or, taken together with the nitrogen atom to which they are attached, R1 -N-R2 and R3-N-R4 can form a heterocyclic ring of the formula: ** Formula ** in which: R5 is a hydrogen atom or a (C1-C3) alkyl group, in which any of the groups (C1-C6) alkyl, aryl, heteroaryl, heterocycloalkyl or cycloalkyl may be optionally further substituted in any of its free positions with one or more groups; and in which a cycloalkyl group may have one or more dob carbon-carbon bonds in the ring, as long as the ring does not become aromatic because of its presence; and wherein a heterocycloalkyl group may have one or more carbon-carbon double bonds or carbon-heteroatom double bonds in the ring, as long as the ring is not made aromatic by its presence; with the proviso that: (E) -3- (3-hydroxyphenyl) -N- [4 - [[4 - [[(E) -3- (3-hydroxyphenyl) prop-2-enoyl] -amino is excluded ] -phenyl] -methyl] -phenyl] -acrylamide and when W is phenyl, other than 0; when W is phenyl and R is hydrogen, R "is other than chlorine, methyl, isopropyl, CF3 or NH2; when W is indazol-5-yl or pyrid-2-yl, R is other than hydrogen, (C1-C3 alkoxy) ); as well as its isomers, tautomers, racemic forms, enantiomers, diastereomers, epimers, mixtures thereof and pharmaceutically acceptable salts thereof.
机译:通式(I)** **的化合物,其中:W为芳基或杂芳基; a为0、1、2或3; R和R'相同或不同,并且彼此独立地选自:氢;卤素; (C1-C3)烷氧基;卤代烷氧基(C1-C2);卤代烷基(C 1 -C 2); NR1R2; CN; SO2NH2;或任选取代的(C 1 -C 6)烷基,芳基或杂芳基;或R”独立地选自:卤素;(C1-C3)烷基;(C1-C3)烷氧基;(C1-C3)烷氧基烷基; C1-C2卤代烷氧基;(C1-C2)卤代烷基; NR3R4;或(CH2)nX- (CH2)mQ,其中:n,m独立为0、1或2; X为直接键; O; S; NH; N-烷基(C1-C3); Q为可选取代的芳基,杂芳基,杂环烷基或环烷基; R1,R2,R3和R4相同或不同,并且彼此独立地为氢原子;(C1-C3)烷基,或与它们相连的氮原子一起,R1 -N-R2和R3-N-R4可以形成下式的杂环:式**,其中:R5是氢原子或(C1-C3)烷基,其中任何基团(C1 -C6)烷基,芳基,杂芳基,杂环烷基或环烷基可在其任何自由位置任选地进一步被一个或多个基团取代;并且其中环烷基可在环中具有一个或多个dob碳-碳键,如只要该环由于存在而不会变成芳香族e;且其中杂环烷基可在环中具有一个或多个碳-碳双键或碳-杂原子双键,只要该环不因其存在而被芳香化;条件是:(E)-3-(3-羟苯基)-N- [4-[[[4-[[(E)-3-(3-羟苯基)丙-2-烯酰基]-氨基被排除] -苯基]-甲基]-苯基]-丙烯酰胺,并且当W为苯基时,除0以外;当W是苯基且R是氢时,R“不是氯,甲基,异丙基,CF3或NH2;当W是吲唑-5-基或吡啶-2-基时,R不是氢,(C1-C3烷氧基));及其异构体,互变异构体,外消旋形式,对映异构体,非对映异构体,差向异构体,它们的混合物及其药学上可接受的盐。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号